| Autor: |
Binish Baig, Sheikh Ahmed, Dr Kaleemullah Mandokhail, Dr Fazal Ur Rehman Zulfiqar Ali, Naeema Anwar, and Dr Ashif Sajjad |
| Jazyk: |
angličtina |
| Rok vydání: |
2018 |
| Předmět: |
|
| DOI: |
10.5281/zenodo.1211634 |
| Popis: |
It is estimated that around more than 2% of the population of world is suffering with hepatitis C virus and death cases because of cirrhosis and liver cancer is more than 350000.The load and epidemiology of HCV infection is different in the different parts of the world. It vary with country particular prevalence range from 10%. In comparison with USA and other urbanized countries the spread of infection in poor countries commonly outcome of contact to infected blood in society settings and healthcare centers. HCV management programs must be country specific which may be different by background and rank of economic progress. Worldwide HCV is a main cause of liver disease and in future it would be a major cause of morbidity and mortality. The complication related to the geographic allocation of HCV infection and its linked risk factor increases its progression. No vaccine is available for HCV and no later than exposure for HCV prophylaxis, so the focal point of most important escaping work must be secure supply of blood, protected management care and people who use drug decrease the number of those people in developing countries. Key words: Hepatitis, Genome, Treatment. Epidemiology |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
